{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "exchange": "ASX", "shortName": "FIREBRICK FPO", "longName": "Firebrick Pharma Limited", "messageBoardId": "finmb_596835469", "market": "au_market", "marketState": "POSTPOST", "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.03, "sharesOutstanding": 175187008, "bookValue": 0.03, "fiftyDayAverage": 0.19445, "fiftyDayAverageChange": -0.02945, "fiftyDayAverageChangePercent": -0.15145281, "twoHundredDayAverage": 0.2495125, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "esgPopulated": false, "regularMarketChangePercent": -5.7142806, "regularMarketPrice": 0.165, "regularMarketChange": -0.00999999, "regularMarketTime": 1683863191, "regularMarketDayHigh": 0.19, "regularMarketDayRange": "0.16 - 0.19", "regularMarketDayLow": 0.16, "regularMarketVolume": 32681, "regularMarketPreviousClose": 0.175, "bid": 0.165, "ask": 0.185, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.17, "averageDailyVolume3Month": 64471, "averageDailyVolume10Day": 135691, "fiftyTwoWeekLowChange": 0.025000006, "fiftyTwoWeekLowChangePercent": 0.17857148, "fiftyTwoWeekRange": "0.14 - 0.415", "fiftyTwoWeekHighChange": -0.24999999, "fiftyTwoWeekHighChangePercent": -0.6024096, "fiftyTwoWeekLow": 0.14, "fiftyTwoWeekHigh": 0.415, "twoHundredDayAverageChange": -0.08451249, "twoHundredDayAverageChangePercent": -0.33871046, "marketCap": 28905858, "priceToBook": 5.5000005, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "firstTradeDateMilliseconds": 1643324400000, "priceHint": 4, "symbol": "FRE.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "440 Collins Street", "address2": "Level 10", "city": "Melbourne", "state": "VIC", "zip": "3000", "country": "Australia", "phone": "1300 301 874", "website": "https://www.firebrickpharma.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Firebrick Pharma Limited engages in the development and commercialization of nasal spray treatment for the common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Peter Laurence Molloy BSc, FAICD, MBA", "age": 68, "title": "Founder, Exec. Chairman & CEO", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": {"raw": 324304, "fmt": "324.3k", "longFmt": "324,304"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Stephen Francis Goodall MASc, MBA", "title": "Founder, COO & Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 250433, "fmt": "250.43k", "longFmt": "250,433"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kavi  Bekarma B.Sc., C.A.", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Simon  Tucker", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Robyn  Branigan", "title": "Head of Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Peter  Friedland", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Monique  Baldwin", "title": "Head of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen  Buckley", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}